CVS Health Corporation [NYSE: CVS] slipped around -1.06 points on Wednesday, while shares priced at $74.01 at the close of the session, down -1.41%. The company report on March 16, 2021 that CVS Health Announces Availability of COVID-19 Antibody Testing in all MinuteClinic Locations in Texas.
Results available within 15 minutes.
CVS Health (NYSE: CVS) announced the availability of COVID-19 antibody testing in all MinuteClinic locations in Texas. There are more than 100 MinuteClinic locations in the state. The point-of-care test assesses for previous exposure to COVID-19 and results are available within 15 minutes. MinuteClinic is the retail medical clinic of CVS Health, with approximately 1,100 locations inside select CVS Pharmacy stores in 33 states and Washington, D.C.
CVS Health Corporation stock is now 8.36% up from its year-to-date (YTD) trading value. CVS Stock saw the intraday high of $74.39 and lowest of $72.88 per share. The company’s 52-week high price is 77.23, which means current price is +8.81% above from all time high which was touched on 01/12/21.
Compared to the average trading volume of 6.91M shares, CVS reached a trading volume of 7899335 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about CVS Health Corporation [CVS]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CVS shares is $85.72 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CVS stock is a recommendation set at 2.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Guggenheim have made an estimate for CVS Health Corporation shares, keeping their opinion on the stock as Neutral, with their previous recommendation back on March 17, 2021. The new note on the price target was released on January 08, 2021, representing the official price target for CVS Health Corporation stock. Previously, the target price had yet another raise to $72, while Piper Sandler analysts kept a Overweight rating on CVS stock.
The Average True Range (ATR) for CVS Health Corporation is set at 1.61, with the Price to Sales ratio for CVS stock in the period of the last 12 months amounting to 0.35. The Price to Book ratio for the last quarter was 1.40, with the Price to Cash per share for the same quarter was set at 8.46. Price to Free Cash Flow for CVS in the course of the last twelve months was 8.79 with Quick ratio for the last quarter at 0.60.
How has CVS stock performed recently?
CVS Health Corporation [CVS] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 1.80. With this latest performance, CVS shares gained by 4.93% in over the last four-week period, additionally plugging by 29.84% over the last 6 months – not to mention a rise of 27.60% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CVS stock in for the last two-week period is set at 58.72, with the RSI for the last a single of trading hit 62.15, and the three-weeks RSI is set at 56.64 for CVS Health Corporation [CVS]. The present Moving Average for the last 50 days of trading for this stock 72.59, while it was recorded at 74.06 for the last single week of trading, and 66.10 for the last 200 days.
CVS Health Corporation [CVS]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and CVS Health Corporation [CVS] shares currently have an operating margin of +5.18 and a Gross Margin at +18.24. CVS Health Corporation’s Net Margin is presently recorded at +2.68.
Return on Total Capital for CVS is now 9.04, given the latest momentum, and Return on Invested Capital for the company is 4.88. Return on Equity for this stock inclined to 10.79, with Return on Assets sitting at 3.11. When it comes to the capital structure of this company, CVS Health Corporation [CVS] has a Total Debt to Total Equity ratio set at 122.56. Additionally, CVS Total Debt to Total Capital is recorded at 55.07, with Total Debt to Total Assets ending up at 35.66. Long-Term Debt to Equity for the company is recorded at 112.36, with the Long-Term Debt to Total Capital now at 50.48.
Receivables Turnover for the company is 12.99 with a Total Asset Turnover recorded at a value of 1.16.CVS Health Corporation’s liquidity data is similarly interesting compelling, with a Quick Ratio of 0.60 and a Current Ratio set at 0.90.
Earnings analysis for CVS Health Corporation [CVS]
With the latest financial reports released by the company, CVS Health Corporation posted 1.91/share EPS, while the average EPS was predicted by analysts to be reported at 1.63/share. When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 17.20%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CVS. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for CVS Health Corporation go to 3.77%.
Insider trade positions for CVS Health Corporation [CVS]
There are presently around $73,679 million, or 78.50% of CVS stock, in the hands of institutional investors. The top three institutional holders of CVS stocks are: VANGUARD GROUP INC with ownership of 105,383,923, which is approximately -0.728% of the company’s market cap and around 0.10% of the total institutional ownership; BLACKROCK INC., holding 92,478,369 shares of the stock with an approximate value of $6.84 billion in CVS stocks shares; and STATE STREET CORP, currently with $4.03 billion in CVS stock with ownership of nearly -3.595% of the company’s market capitalization.
Positions in CVS Health Corporation stocks held by institutional investors increased at the end of February and at the time of the February reporting period, where 1,120 institutional holders increased their position in CVS Health Corporation [NYSE:CVS] by around 57,878,765 shares. Additionally, 818 investors decreased positions by around 57,086,950 shares, while 133 investors held positions by with 880,556,279 shares. The mentioned changes placed institutional holdings at 995,521,994 shares, according to the latest SEC report filing. CVS stock had 265 new institutional investments in for a total of 7,527,394 shares, while 92 institutional investors sold positions of 5,200,959 shares during the same period.